EPIDEMIOLOGY AND LONG-TERM CONSEQUENCES OF HEPATITIS DELTA VIRUS-INFECTION IN THE YUCPA INDIANS OF VENEZUELA

被引:31
作者
HADLER, SC
DEMONZON, MA
RIVERO, D
PEREZ, M
BRACHO, A
FIELDS, H
机构
[1] CTR DIS CONTROL,NATL CTR INFECT DIS,DIV VIRAL & RICKETTSIAL DIS,HEPATITIS BRANCH,ATLANTA,GA 30333
[2] CTR DIS CONTROL,NATL CTR PREVENT SERV,DIV IMMUNIZAT,ATLANTA,GA 30333
[3] DEPT PUBL HLTH,MARACAIBO,VENEZUELA
[4] MINIST HLTH,CARACAS,VENEZUELA
关键词
HEPATITIS-B VIRUS; HEPATITIS VIRUSES;
D O I
10.1093/oxfordjournals.aje.a116472
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
To define better the epidemiology and clinical impact of hepatitis delta virus (HDV) infection among hepatitis B virus (HBV) carriers in less developed countries, the authors prospectively studied a cohort of 216 Yucpa Indian HBV carriers in Venezuela. HBV carriers were followed regularly between 1983 and 1988 by physical examination, laboratory testing for liver enzymes and HBV and HDV markers, and epidemiologic history. Among the cohort, 74 (34%) were initially positive for HDV infection, and 35 additional persons became infected during the study. Risk factors for new HDV infection included living in southern Yucpa villages; being young adults (15-19 years) or young children (1-9 years), and living in a household with a person with acute HDV infection. Persons with HDV infection were at high risk of developing chronic liver disease; 56% of HDV-infected persons had moderate-to-severe chronic liver disease at the end of the study compared with none of the HBV carriers without HDV infection. Mortality rates were 6.9% and 8.8% per year, respectively, among initially HDV-positive HBV carriers and those with new HDV infection, because of rapidly progressive chronic liver disease and fulminant hepatitis; mortality was significantly lower in HBV carriers without HDV infection and in non-HBV carriers. HDV superinfection is a devastating disease in HBV carriers in tropical South America. Prevention of HBV infection with hepatitis B vaccine is the best available tool to reduce the impact of this problem. Am J Epidemiol
引用
收藏
页码:1507 / 1516
页数:10
相关论文
共 27 条
[1]  
Andrade ZA., 1983, REV SOC BRAS MED TRO, V16, P31
[2]  
BENSABATH G, 1983, REV I MED TROP, V25, P182
[3]   HEPATITIS-DELTA VIRUS-INFECTION AND LABREA HEPATITIS - PREVALENCE AND ROLE IN FULMINANT-HEPATITIS IN THE AMAZON BASIN [J].
BENSABATH, G ;
HADLER, SC ;
SOARES, MCP ;
FIELDS, H ;
DIAS, LB ;
POPPER, H ;
MAYNARD, JE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 258 (04) :479-483
[4]   SPECIFIC HISTOLOGIC FEATURES OF SANTA-MARTA HEPATITIS - A SEVERE FORM OF HEPATITIS DELTA-VIRUS INFECTION IN NORTHERN SOUTH-AMERICA [J].
BUITRAGO, B ;
POPPER, H ;
HADLER, SC ;
THUNG, SN ;
GERBER, MA ;
PURCELL, RH ;
MAYNARD, JE .
HEPATOLOGY, 1986, 6 (06) :1285-1291
[5]   EPIDEMIOLOGIC ASPECTS OF SANTA-MARTA HEPATITIS OVER A 40-YEAR PERIOD [J].
BUITRAGO, B ;
HADLER, SC ;
POPPER, H ;
THUNG, SN ;
GERBER, MA ;
PURCELL, RH ;
MAYNARD, JE .
HEPATOLOGY, 1986, 6 (06) :1292-1296
[6]  
de Paola D, 1967, Hospital (Rio J), V71, P1303
[7]  
DEGOTT C, 1988, MICROVESICULAR STEAT
[8]  
Dias L B, 1973, Rev Inst Med Trop Sao Paulo, V15, P86
[9]  
DIMITRAKAKIS M, 1991, HEPATITIS DELTA VIRU, P89
[10]  
FAURE P, 1991, HEPATITIS DELTA VIRU, P452